Global Liquid Biopsy Market Research and Forecast, 2018-2023
Global liquid biopsy market is projected to witness a steady growth during the forecasted period 2018-2023. The rising prevalence of cancer diseases, high investment in R&D and growing preference for minimally invasive technology over alternate invasive methods are the driving factors of the liquid biopsy market. however, lack of awareness in developing and underdeveloped countries hamper the growth of the market. Moreover, technological advancement in a liquid biopsy with growing investment and funding for R&D create a future opportunity for the growth of the market during the forecast period.
Global liquid biopsy market is segmented on the basis of biomarker type, cancer type, and end-user. According to the biomarker type, the market is further sub-segmented as circulating tumor cells, circulating tumor DNA and others such as extracellular vesicles. According to the cancer type, the market is further diversified as lung cancer, breast cancer, prostate cancer, colorectal cancer, and others. Moreover, according to the end-user, the market is further diversified as hospitals and laboratories, and academic and research institutes.
Global liquid biopsy market can be geographically segmented into North America, Europe, Asia-Pacific and Rest of the World. High prevalence of cancer diseases and the investment in R&D in the US has boosted the growth of the market in North America. The rapidly developing economies of Asia-Pacific are projected to witness the highest growth rate during the forecasted period. The growth in the Asia-Pacific market is backed by the growing awareness about the diagnosis and treatment for cancer diseases within the countries. Along with it, efforts by the government funding on research programs is aiding in the growth of the Asia-Pacific liquid biopsy market.
The key players of the global liquid biopsy market include Biocept Inc., Bio-Rad Laboratories Inc., Biodesix Inc., Hoffmann-La Roche Ltd., and others. The players have adopted inorganic growth strategies for enhancing their overall revenue. With these strategies, the players aimed at advancing innovation and investing significantly in medical needs.
RESEARCH METHODOLOGY
The market study of liquid biopsy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE:
MARKET SEGMENTATION:
Global Liquid Biopsy Market Research and Analysis by Biomarker Type
Global Liquid Biopsy Market Research and Analysis by Cancer Type
Global Liquid Biopsy Market Research and Analysis by End-User
Global Liquid Biopsy Market Research and Analysis by Region
THE REPORT COVERS:
Global liquid biopsy market is segmented on the basis of biomarker type, cancer type, and end-user. According to the biomarker type, the market is further sub-segmented as circulating tumor cells, circulating tumor DNA and others such as extracellular vesicles. According to the cancer type, the market is further diversified as lung cancer, breast cancer, prostate cancer, colorectal cancer, and others. Moreover, according to the end-user, the market is further diversified as hospitals and laboratories, and academic and research institutes.
Global liquid biopsy market can be geographically segmented into North America, Europe, Asia-Pacific and Rest of the World. High prevalence of cancer diseases and the investment in R&D in the US has boosted the growth of the market in North America. The rapidly developing economies of Asia-Pacific are projected to witness the highest growth rate during the forecasted period. The growth in the Asia-Pacific market is backed by the growing awareness about the diagnosis and treatment for cancer diseases within the countries. Along with it, efforts by the government funding on research programs is aiding in the growth of the Asia-Pacific liquid biopsy market.
The key players of the global liquid biopsy market include Biocept Inc., Bio-Rad Laboratories Inc., Biodesix Inc., Hoffmann-La Roche Ltd., and others. The players have adopted inorganic growth strategies for enhancing their overall revenue. With these strategies, the players aimed at advancing innovation and investing significantly in medical needs.
RESEARCH METHODOLOGY
The market study of liquid biopsy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE:
- Financial reports of companies involved in the market
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog.
MARKET SEGMENTATION:
Global Liquid Biopsy Market Research and Analysis by Biomarker Type
Global Liquid Biopsy Market Research and Analysis by Cancer Type
Global Liquid Biopsy Market Research and Analysis by End-User
Global Liquid Biopsy Market Research and Analysis by Region
THE REPORT COVERS:
- Comprehensive research methodology of global liquid biopsy market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global liquid biopsy market.
- Insights about market determinants which are stimulating the global liquid biopsy market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
CHAPTER 1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
CHAPTER 3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. High Prevalence of Cancer Diseases Globally
3.1.2. Preference of Minimally Invasive Method Over Alternate Invasive Method
3.1.3. Rising Investment and Funding for Liquid Biopsy along with increasing R&D
3.1.4. Collaboration Between Companies and Public Organization
3.2. Restraints
3.2.1. Lack of Awareness in Developing and Underdeveloped Regions
3.3. Opportunities
3.3.1. Technological Advancement in Liquid Biopsy
CHAPTER 4. MARKET SEGMENTATION
4.1. Global Liquid Biopsy Market by Biomarker Type
4.1.1. Circulating Tumor Cells
4.1.2. Circulating Tumor DNA (ctDNA)
4.1.3. Others (Extracellular Vesicles)
4.2. Global Liquid Biopsy Market by Cancer Type
4.2.1. Lung Cancer
4.2.2. Breast Cancer
4.2.3. Prostate Cancer
4.2.4. Colorectal Cancer
4.2.5. Other Cancers
4.3. Global Liquid Biopsy Market by End-User
4.3.1. Hospitals and Laboratories
4.3.2. Academic and Research Centres
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
CHAPTER 6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of The World
CHAPTER 7. COMPANY PROFILES
7.1. Biocept Inc.
7.2. Biodesix, Inc.
7.3. Bio-Rad Laboratories Inc.
7.4. CellMax Life
7.5. Circulogene
7.6. Clearbridge Biomedics Pte Ltd.
7.7. Cynvenio Biosystems, Inc.
7.8. Epigenomics AG
7.9. Exosome Diagnostics Inc.
7.10. F. Hoffmann-La Roche AG
7.11. Genomic Health Inc.
7.12. Guardant Health Inc.
7.13. Inivata Ltd.
7.14. Lariat Biosciences, Inc.
7.15. MDxHealth SA
7.16. Menarini-Silicon Biosystems
7.17. Personal Genome Diagnostics Inc.
7.18. QIAGEN NV
7.19. Raindance Technologies, Inc.
7.20. Thermo Fisher Scientific Inc.
7.21. Trovagene, Inc.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
CHAPTER 3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. High Prevalence of Cancer Diseases Globally
3.1.2. Preference of Minimally Invasive Method Over Alternate Invasive Method
3.1.3. Rising Investment and Funding for Liquid Biopsy along with increasing R&D
3.1.4. Collaboration Between Companies and Public Organization
3.2. Restraints
3.2.1. Lack of Awareness in Developing and Underdeveloped Regions
3.3. Opportunities
3.3.1. Technological Advancement in Liquid Biopsy
CHAPTER 4. MARKET SEGMENTATION
4.1. Global Liquid Biopsy Market by Biomarker Type
4.1.1. Circulating Tumor Cells
4.1.2. Circulating Tumor DNA (ctDNA)
4.1.3. Others (Extracellular Vesicles)
4.2. Global Liquid Biopsy Market by Cancer Type
4.2.1. Lung Cancer
4.2.2. Breast Cancer
4.2.3. Prostate Cancer
4.2.4. Colorectal Cancer
4.2.5. Other Cancers
4.3. Global Liquid Biopsy Market by End-User
4.3.1. Hospitals and Laboratories
4.3.2. Academic and Research Centres
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
CHAPTER 6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of The World
CHAPTER 7. COMPANY PROFILES
7.1. Biocept Inc.
7.2. Biodesix, Inc.
7.3. Bio-Rad Laboratories Inc.
7.4. CellMax Life
7.5. Circulogene
7.6. Clearbridge Biomedics Pte Ltd.
7.7. Cynvenio Biosystems, Inc.
7.8. Epigenomics AG
7.9. Exosome Diagnostics Inc.
7.10. F. Hoffmann-La Roche AG
7.11. Genomic Health Inc.
7.12. Guardant Health Inc.
7.13. Inivata Ltd.
7.14. Lariat Biosciences, Inc.
7.15. MDxHealth SA
7.16. Menarini-Silicon Biosystems
7.17. Personal Genome Diagnostics Inc.
7.18. QIAGEN NV
7.19. Raindance Technologies, Inc.
7.20. Thermo Fisher Scientific Inc.
7.21. Trovagene, Inc.
LIST OF TABLES
TABLE # 1 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL CIRCULATING TUMOR CELLS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL CIRCULATING TUMOR DNA MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL OTHER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL HOSPITALS AND LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 16 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 17 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 18 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 19 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 20 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 21 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 22 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 24 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 25 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 26 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 27 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 28 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 29 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 1 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL CIRCULATING TUMOR CELLS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL CIRCULATING TUMOR DNA MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL OTHER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL HOSPITALS AND LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 16 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 17 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 18 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 19 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 20 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 21 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 22 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 24 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 25 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 26 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 27 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 28 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 29 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL LIQUID BIOPSY MARKET SHARE BY BIOMARKER TYPE, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL LIQUID BIOPSY MARKET SHARE BY CANCER TYPE, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL LIQUID BIOPSY MARKET SHARE BY END-USER, 2017 VS 2023 (%)
FIGURE # 4 GLOBAL LIQUID BIOPSY MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
FIGURE # 5 US LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 UK LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 FRANCE LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 ITALY LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 SPAIN LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 ROE LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 INDIA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 JAPAN LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 REST OF THE WORLD LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL LIQUID BIOPSY MARKET SHARE BY BIOMARKER TYPE, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL LIQUID BIOPSY MARKET SHARE BY CANCER TYPE, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL LIQUID BIOPSY MARKET SHARE BY END-USER, 2017 VS 2023 (%)
FIGURE # 4 GLOBAL LIQUID BIOPSY MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
FIGURE # 5 US LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 UK LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 FRANCE LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 ITALY LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 SPAIN LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 ROE LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 INDIA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 JAPAN LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 REST OF THE WORLD LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
